Tran J, Mirzaei M, Anderson L, Leeder SR. The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci. 2010;295:38–40.
Article
Google Scholar
Depta JP, Bhatt DL. New approaches to inhibiting platelets and coagulation. Annu Rev Pharmacol Toxicol. 2015;55:373–97.
Article
CAS
Google Scholar
Bray PF. Platelet Hyperreactivity: predictive and intrinsic properties. Hematol Oncol Clin North Am. 2007;21:633–vi.
Article
Google Scholar
Cha JK, Jeong MH, Jang JY, Bae HR, Lim YJ, Kim JS, et al. Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovas Dis (Basel, Switzerland). 2003;16:376–82.
Article
CAS
Google Scholar
Lukasik M, Rozalski M, Luzak B, Michalak S, Kozubski W, Watala C. Platelet activation and reactivity in the convalescent phase of ischaemic stroke. Thromb Haemost. 2010;103:644–50.
Article
CAS
Google Scholar
Anyanwu CHM, Nath M, Li J, Barone FC, Rosenbaum DM, Zhou J. Platelets pleiotropic roles in ischemic stroke. Austin J Cerebrovasc Dis Stroke. 2016;3:1048.
Google Scholar
Järemo P, Eriksson M, Lindahl T, Nilsson S, Milovanovic M. Platelets and acute cerebral infarction2012.
Pawelczyk M, Chmielewski H, Kaczorowska B, Przybyła M, Baj Z. Platelet reactivity in patients with stroke and hyperlipidemia, GPIbα assessment. Clin Appl Thromb/Hemost. 2016;22:166–70.
Article
CAS
Google Scholar
O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–23.
Article
Google Scholar
Mayda-Domac F, Misirli H, Yilmaz M. Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis. 2010;19:66–72.
Article
Google Scholar
McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol. 2004;126:861–9.
Article
Google Scholar
Yip H-K, Chen S-S, Liu JS, Chang H-W, Kao Y-F, Lan M-Y, et al. Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation. Stroke. 2004;35:1683–7.
Article
Google Scholar
Cevik O, Baykal AT, Sener A. Platelets proteomic profiles of acute ischemic stroke patients. PLoS ONE. 2016;11:e0158287.
Article
Google Scholar
Kalmarova K, Kurca E, Nosal V, Dluha J, Ballova J, Sokol J, et al. Measurement of platelet p-selectin expression by flow cytometry in patients with acute ischemic stroke. Acta Medica Martiniana. 2018;18:14–20.
Article
Google Scholar
Marquardt L, Anders C, Buggle F, Palm F, Hellstern P, Grau AJ. Leukocyte-platelet aggregates in acute and subacute ischemic stroke. Cerebrovasc Dis (Basel, Switzerland). 2009;28:276–82.
Article
CAS
Google Scholar
McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol. 2004;125:777–87.
Article
Google Scholar
Garlichs CD, Kozina S, Fateh-Moghadam S, Handschu R, Tomandl B, Stumpf C, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke. 2003;34:1412–8.
Article
CAS
Google Scholar
Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, Stellos K, et al. Course of platelet activation and platelet–leukocyte interaction in cerebrovascular ischemia. Stroke. 2006;37:2283–7.
Article
CAS
Google Scholar
Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33:2570–4.
Article
CAS
Google Scholar
Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR, et al. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res. 2009;124:213–8.
Article
CAS
Google Scholar
Ilhan D, Özbabalik D, Gulcan E, Özdemir Ö, Gülbaçs Z. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke. Neurologist. 2010;16:188–91.
Article
Google Scholar
Halawani SHWD, Webster J, Greaves M, Ford I. Aspirin failure in patients presenting with acute cerebrovascular ischaemia. Thromb Haemost. 2011;106:240–7.
Article
CAS
Google Scholar
Sabra A, Stanford SN, Storton S, Lawrence M, D’Silva L, Morris RHK, et al. Assessment of platelet function in patients with stroke using multiple electrode platelet aggregometry: a prospective observational study. BMC Neurol. 2016;16:254.
Article
Google Scholar
Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res. 2001;104:197–205.
Article
CAS
Google Scholar
Singh N, Gemmell CH, Daly PA, Yeo EL. Elevated platelet-derived microparticle levels during unstable angina. Can J Cardiol. 1995;11:1015–21.
CAS
PubMed
Google Scholar
Schmalbach B, Stepanow O, Jochens A, Riedel C, Deuschl G, Kuhlenbaumer G. Determinants of platelet-leukocyte aggregation and platelet activation in stroke. Cerebrovasc Dis (Basel, Switzerland). 2015;39:176–80.
Article
CAS
Google Scholar
Serebruany VL, Malinin AI, Oshrine BR, Sane DC, Takserman A, Atar D, et al. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy. Thromb Res. 2004;113:197–204.
Article
CAS
Google Scholar
Brass LF. Thrombin and platelet activation. Chest. 2003;124:18s–25s.
Article
CAS
Google Scholar
Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res. 2006;99:1293–304.
Article
CAS
Google Scholar